A simple fecal sample may be able to predict your patient’s risk for developing type 2 diabetes. That’s right, not a blood test, but a STOOL test. Our microbiome, the ecological community of microorganisms that share our bodies, influence our risk for disease. And not just irritable bowel syndrome but many other diseases including type 2 diabetes, depression, cancer, asthma, psoriasis, and autism.1 Research regarding the connections between our microbiome and... Read More
In these multimedia presentations, our moderator reviews a research manuscript and an expert panel discusses its strengths, weaknesses, and potential implications for practice.
Succinct reviews that discuss the potential impact of recently published manuscripts on ambulatory care pharmacy practice. Read the commentaries and voice your own opinions.
Featured Panel Discussion
The CONQUER study was double-blind, placebo-controlled clinical trial that examined the potential benefits of the combination product Qsymia (phenterimine and topiramate) in patients who were overweight and obese. Our moderator and panelists explore the findings of this study and how this new information should be applied to practice.
Tell us what you think? Given safety concerns that have resulted in restrictions in its prescribing and dispensing, when... Read More